LAB Earnings

LAB reported its FY2025Q3 earnings on 2025-11-04, showcasing a revenue of 19.55M against an estimate of 18.00M, resulting in a 8.62% surprise. The EPS was -0.09, surpassing the expected -0.04 by -125%. The stock experienced a -4.2% price change on the earnings day and a -1.68% change over the next five days, reflecting market reactions to the results.

Following LAB's FY2025Q3 earnings announcement on 2025-11-04, the stock price moved by -4.2% on the day of the release. Over the subsequent five days, it saw a -1.68% change. Historically, LAB's stock price tends to shift by an average of 5.25% in the 10 days leading up to earnings and 1.27% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate LAB's annual revenue to reach 18.60M, while the EPS is projected at -0.01. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between LAB's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, LAB's stock price typically moves by 5.25% in the 10 days before its earnings and 1.27% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of -0.01 and revenue of 18.60M.

The earnings call presents mixed signals: strong cost management and cash position are positive, but declining revenues, gross margins, and ongoing cash burn are concerning. The optimistic guidance and strategic partnerships offer potential upside, yet uncertainties in revenue timing and market conditions temper expectations. The Q&A session reveals cautious optimism but lacks clarity on key issues. Overall, the stock price is likely to remain neutral in the short term as positive strategic moves are counterbalanced by financial and operational challenges.